openPR Logo
Press release

Global Rheumatology Therapeutics Market poised to grow at a CAGR of 2.52 % by 2024: Infinium Global Research

02-20-2018 11:49 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Infinium Global Research

Infinium Global Research

Infinium Global Research

The report on Rheumatology Therapeutics Market by Drug Class (disease modifying anti-rheumatic, nonsteroidal anti-inflammatory, corticosteroids, uric acid drugs), by Disease Indication (rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis), and by Distribution Channel (hospital, retail, online pharmacy) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Rheumatology Therapeutics Market is projected to grow at a CAGR of 2.52% in terms of value over the period of 2018-2024.

Get 15% discount for Global rheumatology therapeutics Market: https://www.infiniumglobalresearch.com/Reports/requestdiscount/1129

The recent report on global rheumatology therapeutics market identified that North America dominated the global rheumatology therapeutics market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the rheumatology therapeutics Market worldwide. Increasing incidences of rheumatic arthritis in North America and Europe owing to rising pool of geriatric population is a primary factor driving the growth in the world market. Furthermore, growing per capita healthcare expenditure coupled with rising number of patients over 50 years of age are likely to offer susbtantail growth opportunities in the Asia-Pacific region, as a result the Asia-Pacific rhematology therapeutics market is expected to grow at the highest CAGR over the forecast period-identifies Infinium Global Research.

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global rheumatology therapeutics market but also make strategic decisions to capture the most lucrative markets in the near future.

The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018 to 2024.The report segments the global rheumatology therapeutics market on the basis of drug class, disease indication, and distribution channel.

Get Free Sample Pages of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/1129

Global Rheumatology Therapeutics Market by Drug Class
• Disease Modifying Anti-rheumatic Drugs
• Nonsteroidal Anti-inflammatory Drugs
• Corticosteroids
• Uric Acid Drugs
• Others

Global Rheumatology Therapeutics Market by Disease Indication
• Rheumatoid Arthritis
• Osteoarthritis
• Gout
• Gout
• Ankylosing Spondylitis
• Others

Global Rheumatology Therapeutics Market by Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Rheumatology Therapeutics Market by Regions
• North America
• Europe
• Asia-Pacific
• RoW

Companies Profiled in the report
• Takeda Pharmaceutical
• Sanofi
• Genentech, Inc.
• Novartis AG
• Janssen Biotech, Inc.
• Amgen, Inc.
• AbbVie, Inc.
• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Merck & Co., Inc

Browse Complete TOC of this Report: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_rheumatology_therapeutics_market

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

About Us:

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you.

Contact Us:

Infinium Global Research
Goyal Shinde Park, Bhau Patil Road,
Bopodi, Pune-411 020.
U.S. + Canada Toll Free: 1-800-638-0796
Email: sales@infiniumglobalresearch.com
Website: https://www.infiniumglobalresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Rheumatology Therapeutics Market poised to grow at a CAGR of 2.52 % by 2024: Infinium Global Research here

News-ID: 950000 • Views:

More Releases from Infinium Global Research

Global High-End Inertial Sensing Market to Reach USD 10.46 Billion by 2032, Growing at a CAGR of 5.8%
Global High-End Inertial Sensing Market to Reach USD 10.46 Billion by 2032, Grow …
The global high-end inertial sensing market is experiencing substantial growth as industries increasingly demand precision, reliability, and automation. According to Infinium Global Research, the market was valued at USD 6.35 billion in 2023 and is expected to reach USD 10.46 billion by 2032, registering a CAGR of 5.80% during 2024-2032. High-end inertial sensing systems integrate advanced sensors such as gyroscopes, accelerometers, magnetometers, and inertial measurement units to provide precise navigation
Global CMOS Image Sensor Market to Reach USD 55 Billion by 2032, Driven by a 7% CAGR
Global CMOS Image Sensor Market to Reach USD 55 Billion by 2032, Driven by a 7% …
The global CMOS image sensor market has established itself as a critical segment within the imaging technology industry. Valued at USD 30.43 billion in 2023, the market is projected to reach USD 55.00 billion by 2032, expanding at a CAGR of 7.00% during the forecast period. CMOS (Complementary Metal-Oxide-Semiconductor) image sensors are essential components that convert light into electrical signals for image processing, powering a wide array of applications from
Magnetic Sensors Market Forecast 2024-2032: CAGR of 6.4% Signals Strong Growth Across Automotive, Healthcare, and Consumer Electronics
Magnetic Sensors Market Forecast 2024-2032: CAGR of 6.4% Signals Strong Growth A …
The global magnetic sensors market has become a cornerstone in modern electronics, automotive, and industrial applications. According to Infinium Global Research, the market was valued at USD 3.43 billion in 2023 and is projected to reach USD 5.94 billion by 2032, reflecting a CAGR of 6.40% during the forecast period. Magnetic sensors detect and measure magnetic fields, converting the information into electrical signals for accurate measurement of strength, direction, and
RF Front End Module Market to Reach USD 21.93 Billion by 2032, Driven by Growing 5G and IoT Adoption Worldwide
RF Front End Module Market to Reach USD 21.93 Billion by 2032, Driven by Growing …
The global RF Front End Module Market has become a cornerstone of the modern communications ecosystem, playing an essential role in mobile devices, wireless infrastructure, and connected technologies. According to a recent report by Infinium Global Research (IGR), the market was valued at USD 13.43 billion in 2023 and is projected to reach USD 21.93 billion by 2032, growing at a CAGR of 5.70% during 2024-2032. The RF front end

All 5 Releases


More Releases for Rheumatology

Understanding the Rheumatology Market: Segments & Scope
According to The Insight Partners, the rheumatology market is broadly segmented by: • Drug class: nonsteroidal anti inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and disease modifying anti rheumatic drugs (DMARDs). • Disease indications: rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis. • Distribution channels: hospital pharmacies, retail pharmacies, online pharmacies. • Geography: the usual regions (North America, Europe, Asia Pacific, South & Central America, etc.) with further country level breakdowns. CAGR (Compound Annual Growth
Increasing Autoimmune Disease Prevalence Drives Rheumatology Therapeutics Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rheumatology Therapeutics Market Size Growth Forecast: What to Expect by 2025? The market for rheumatology therapeutics has seen robust growth in the recent past. The market size is expected to expand from $42.4 billion in 2024 to $44.61 billion in 2025, marking a compound annual growth rate (CAGR) of
Rheumatology Therapeutics Market to Hit $59.1 Billion by 2030
◉ Global Rheumatology Therapeutics Market Set to Reach USD 59.1 Billion by 2030, Driven by Aging Population and Innovation The global rheumatology therapeutics market is poised for steady growth, projected to reach nearly USD 59.1 billion by 2030, expanding at a CAGR of 2.7% from 2024 to 2030, according to Maximize Market Research. This growth is fueled by an aging global population, rising prevalence of rheumatic diseases, and continuous advancements in
Rheumatology Therapeutics Market 2023 Driving Factors Forecast Research 2029
Rheumatology Therapeutics market is anticipated to grow at a CAGR of 3.2% during the forecast period (2023-2030). Therapeutic drugs are used to slow down the progression of certain autoimmune rheumatic diseases such as rheumatic arthritis (RA). The increasing prevalence of RA globally has bolstered the launch of novel therapeutic agents and favorable refurbishment policies for high-cost treatment products are some of the factors driving the market growth. According to the
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty December 05-06, 2022 | Dubai, UAE Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc. Audience Profile: ·
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market. A report by Transparency Market Research uncovers after in-depth study that the global rheumatology